Colorectal Cancer: Related News

On Our Blog

Pictured: Julio Garcia-Aguilar
What Are the Benefits of Minimally Invasive Colorectal Surgery?

In this Ask the Expert feature, colorectal surgeon Julio Garcia-Aguilar discusses the differences between laparoscopy and robotic surgery and explains which patients are the best candidates for these procedures.

March 25, 2014
Pictured: Oliver Zivanovic, Garrett Nash & Dennis Chi
Heated Chemotherapy: Using Robust Science to Guide Clinical Decisions

Memorial Sloan Kettering experts are leading investigations of a procedure called hyperthermic intraperitoneal chemotherapy, also known as HIPEC.

November 15, 2013
Pictured: Joanne Frankel Kelvin, Nadeem  Abu-Rustum & Larissa Temple
Cancer’s Impact on Women’s Fertility and Building a Family after Treatment

Memorial Sloan Kettering experts discuss the impact that cancer and its treatment can have on female fertility, and options for building a family after treatment ends.

September 16, 2013
Strategies for Women to Cope with Sexual and Vaginal Health Concerns Related to Cancer

Therapies are often available for women dealing with sexual and vaginal health concerns related to cancer and its treatment.

June 14, 2013
Pictured: David Finley & Maria Teresa Ruiz Tsukazan
Robot-Assisted Surgery at Memorial Sloan Kettering

Our doctors introduce and apply advanced technologies in minimal-access surgery to benefit patients.

February 25, 2013
Pictured: Martin Weiser
More-Accurate Colorectal Cancer Staging Helps Doctors Personalize Treatment

Memorial Sloan Kettering’s colorectal cancer team has developed online prediction tools that assess disease risk following surgery, enabling patients and physicians to make better treatment decisions.

November 8, 2012
Cancer Genomics: Improved Understanding of Molecular Changes in Tumors Produces More-Specialized Treatments

With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.

September 21, 2012
Pictured: Leonard Saltz
Leonard Saltz Named Chief of Gastrointestinal Oncology Service

Dr. Saltz, an internationally recognized expert in developing new drug therapies for colorectal cancer, joined the Memorial-Sloan Kettering faculty in 1989.

June 6, 2012
Pictured: Ann Zauber
Study Finds Colonoscopy Prevents Deaths from Colon Cancer

For the first time, a new study has shown that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease.

February 23, 2012
New Technology Will Improve Molecular Testing of Tumors for Patients

Memorial Sloan Kettering has made an important step forward in efficiently diagnosing gene mutations in patients’ cancers on an individual basis.

June 1, 2010

Related Media Coverage

Uterine Cancer Tied to Later Colon Cancer

Gynecologist and geneticist Noah Kauff commented on a study that found that women diagnosed with uterine cancer may have a higher risk of developing colon cancer later in life. He said the increased risk could be due to women with a hereditary condition known as Lynch syndrome.

April 11, 2013
New Way of Expanding Cancer Screening for Minority Women

Minority patients have a significantly decreased survival from colon cancer compared to white patients, most often as a result of a late diagnosis. To help address this problem, a team of healthcare professionals at Memorial Sloan Kettering Cancer Center has identified an efficient way to increase minority access to lifesaving colorectal cancer screening (CRCS) in communities where multiple barriers to preventive care exist.

October 25, 2010
Surgery Not Necessary for Most Late-Stage Colorectal Cancers

A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don’t require immediate surgery to remove the primary tumor in the colon.

May 30, 2009
New Study Examines Effectiveness of Colorectal Cancer Screening Tests and Suggests Screening May Be Stopped at Age 75

New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75.

October 6, 2008